Type 2 diabetes is a common yet complex disorder in which the key hormone for nutrient storage, insulin, is both ineffective and insufficient in most affected patients, resulting in high circulating levels of glucose. Most persons with type 2 diabetes have lost 80% of their ability to secrete insulin by…
The New England Journal of Medicine: Search Results in Gastroenterology
In a phase 3 trial, adults with type 2 diabetes who had not previously received insulin were assigned to receive once-weekly efsitora or once-daily degludec. Efsitora was noninferior to degludec in reducing glycated hemoglobin levels.
The New England Journal of Medicine: Search Results in Endocrinology
Long-term oxygen therapy, the first intervention that was shown to improve survival in patients with both severe hypoxemia and chronic obstructive pulmonary disease (COPD), had an effect size so large that data from fewer than 300 patients were all that was needed to establish its efficacy. In the Nocturnal Oxygen…
The New England Journal of Medicine: Search Results in Pulmonary/Critical Care
Oxygen therapy prolongs survival in patients with severe hypoxemia but is a burden. In this trial, therapy for 24 rather than 15 hours per day did not reduce the risk of hospitalization or death at 1 year.
The New England Journal of Medicine: Search Results in Pulmonary/Critical Care
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Google comparecerá ante los tribunales para hacer frente a las acusaciones de monopolio publicitario. Los expertos afirman que una victoria del Departamento de Justicia de EE UU podría crear un mejor futuro para la navegación.
Google comparecerá ante los tribunales para hacer frente a las acusaciones de monopolio publicitario. Los expertos afirman que una victoria del Departamento de Justicia de EE UU podría crear un mejor futuro para la navegación. Noticias sobre negocios
Luca Ferrari, el Director General de la empresa lo confirma: necesitan un equipo más pequeño y especializado.
Luca Ferrari, el Director General de la empresa lo confirma: necesitan un equipo más pequeño y especializado. Noticias sobre negocios
In two replicate trials, depemokimab, an ultra-long-acting anti–interleukin-5 biologic therapy, reduced exacerbations in patients who had severe asthma with an eosinophilic phenotype.
The New England Journal of Medicine: Search Results in Pulmonary/Critical Care
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
